JERUSALEM, July 05, 2022 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq: DRTS) (“Alpha Tau” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it will host a hybrid in-person/virtual key opinion leader (KOL) meeting at Convene (North Hub Room), located at 530 5th Ave. New York, NY on Monday, July 18, 2022 beginning at 10:30 am Eastern Time. For those attending in-person, breakfast will begin at 10:30 am Eastern Time. For those attending virtually, the presentations and webcast will begin at 11:00 am Eastern Time.
Read more here.
![[Axiom Space in FOX] SpaceX, Axiom Space delay first launch with all-European crew until Thursday](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
![[Binah.ai in Cision PR WEb] Binah.ai Welcomes Digital Health Leader Mark H. Goldstein as Chairman of its Advisory Board and Investor](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-link.svg)
